- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
-
- 长期趋势：
已有390家主力机构披露2024-12-31报告期持股数据，持仓量总计1.03亿股，占流通A股8.48%
- 波段诊断：
-
技术面诊股
诊断结果：5.3技术面打败了97%的股票
技术面评分前10的股票
近期的平均成本为28.34元。
平均成本
近期的平均成本为28.34元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"28.34","date":1744880372,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2025.04.18","stock":"-0.98","trade":"-0.37","ind":"-0.11"},{"date":"2025.04.17","stock":"-1.38","trade":"0.74","ind":"0.13"},{"date":"2025.04.16","stock":"2.14","trade":"-1.23","ind":"0.26"},{"date":"2025.04.15","stock":"0.57","trade":"0.11","ind":"0.15"},{"date":"2025.04.14","stock":"-0.14","trade":"1.30","ind":"0.76"},{"date":"2025.04.11","stock":"-0.35","trade":"-0.33","ind":"0.45"},{"date":"2025.04.10","stock":"3.04","trade":"1.99","ind":"1.16"},{"date":"2025.04.09","stock":"4.90","trade":"1.27","ind":"1.31"},{"date":"2025.04.08","stock":"2.37","trade":"1.75","ind":"1.58"},{"date":"2025.04.07","stock":"-2.47","trade":"-10.73","ind":"-7.34"},{"date":"2025.04.03","stock":"1.74","trade":"0.20","ind":"-0.24"},{"date":"2025.04.02","stock":"0.62","trade":"0.05","ind":"0.05"},{"date":"2025.04.01","stock":"3.29","trade":"2.74","ind":"0.38"},{"date":"2025.03.31","stock":"-0.12","trade":"-1.80","ind":"-0.46"},{"date":"2025.03.28","stock":"-2.16","trade":"-1.13","ind":"-0.67"},{"date":"2025.03.27","stock":"3.16","trade":"0.27","ind":"0.15"},{"date":"2025.03.26","stock":"-1.48","trade":"0.06","ind":"-0.04"},{"date":"2025.03.25","stock":"2.08","trade":"1.13","ind":"-0.00"},{"date":"2025.03.24","stock":"-0.73","trade":"-1.69","ind":"0.15"},{"date":"2025.03.21","stock":"-2.17","trade":"-1.72","ind":"-1.29"},{"date":"2025.03.20","stock":"1.40","trade":"-0.71","ind":"-0.51"}]
益丰药房,上证指数,医药商业指数
压力支撑
该股压力位为28.18元，支撑位为27.76元。
[{"text":"\u538b\u529b\u4f4d","value":"28.18","date":1744905600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"27.76","date":1744905600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.0资金面打败了71%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月18日 20:31
| 机构今日流向(万元) | -761.09 | 机构5日流向(万元) | -2216.20 |
| 机构10日流向(万元) | -3710.52 | 机构20日流向(万元) | -8385.37 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少74894.46万股，其中基金净减仓23家，主力净减仓19家，请投资者中长期谨慎为宜。
截止2024-12-31，共390家主力机构（基金390家），持仓量总计10280.4万股，占流通A股8.48%
其中，基金持仓与2024-06-30相比：
增仓：78家 ，增持 1897.91万股
减仓：101家 ，减持 1784.61万股
新出现在主力名单中：185家 ，持有3546.43万股
从主力名单中消失：204家 ，原持有78554.19万股
其中，基金持仓与2024-06-30相比：
增仓：78家 ，增持 1897.91万股
减仓：101家 ，减持 1784.61万股
新出现在主力名单中：185家 ，持有3546.43万股
从主力名单中消失：204家 ，原持有78554.19万股
消息面诊股
诊断结果：5.5消息面打败了61%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 益丰药房：4月17日获融资买入1172.09万元
2025-04-18 - 上市公司2024年报分红总额超1.1万亿元
2025-04-18 - 益丰药房：4月16日获融资买入676.96万元，占
2025-04-17 - 益丰药房：4月15日获融资买入596.82万元，占
2025-04-16 - 增收不增利？药店打响“收缩战”
2025-04-15 - 益丰药房：4月14日获融资买入439.88万元
2025-04-15 - 券商观点|医药生物行业周报：FDA将逐步取消对单抗
2025-04-14 - 【国金医药·行业周报】医药回调是重大机遇，创新药是
2025-04-14 - 闭店1662家：国大药房暂退“万店俱乐部”，医药零
2025-04-14 - 益丰药房：4月11日获融资买入1180.47万元
2025-04-12
消息列表
| 一般消息 | 高管变动 | 因个人原因 | 2025-04-02 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-01-11 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2024-08-30 |
| 利好 | 分红转增 | 10转2.0股派5.0元(含税) | 2024-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-04-29 |
| 一般消息 | 高管变动 | 公司董事会对第四届董事会审计委员会... | 2024-04-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：1.6行业面打败了19%的股票
医药商业行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2025.04.18","price":"-0.11","value":"-0.37"},{"date":"2025.04.17","price":"0.13","value":"0.74"},{"date":"2025.04.16","price":"0.26","value":"-1.23"},{"date":"2025.04.15","price":"0.15","value":"0.11"},{"date":"2025.04.14","price":"0.76","value":"1.30"},{"date":"2025.04.11","price":"0.45","value":"-0.33"},{"date":"2025.04.10","price":"1.16","value":"1.99"},{"date":"2025.04.09","price":"1.31","value":"1.27"},{"date":"2025.04.08","price":"1.58","value":"1.75"},{"date":"2025.04.07","price":"-7.34","value":"-10.73"},{"date":"2025.04.03","price":"-0.24","value":"0.20"},{"date":"2025.04.02","price":"0.05","value":"0.05"},{"date":"2025.04.01","price":"0.38","value":"2.74"},{"date":"2025.03.31","price":"-0.46","value":"-1.80"},{"date":"2025.03.28","price":"-0.67","value":"-1.13"},{"date":"2025.03.27","price":"0.15","value":"0.27"},{"date":"2025.03.26","price":"-0.04","value":"0.06"},{"date":"2025.03.25","price":"-0.00","value":"1.13"},{"date":"2025.03.24","price":"0.15","value":"-1.69"},{"date":"2025.03.21","price":"-1.29","value":"-1.72"},{"date":"2025.03.20","price":"-0.51","value":"-0.71"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 益丰药房 | 12.17% | 0.18% | 5.3分 |
| 2 | 大参林 | 10.92% | -0.35% | 5.4分 |
| 3 | 南京医药 | -1.19% | 4.63% | 5.2分 |
| 4 | 一心堂 | -3.15% | 1.81% | 4.0分 |
| 5 | 上海医药 | -3.54% | -0.48% | 5.4分 |
| 6 | 国药股份 | -4.44% | -0.65% | 4.6分 |
| 8 | 英特集团 | -5.22% | 2.78% | 5.0分 |
| 10 | 重药控股 | -5.83% | 0.41% | 4.7分 |
| 12 | 国药一致 | -6.59% | 0.16% | 4.9分 |
| 14 | 浙江震元 | -6.93% | 1.32% | 4.3分 |
| 16 | 瑞康医药 | -7.57% | 0.72% | 4.4分 |
| 18 | 柳药集团 | -9.58% | 0.66% | 4.6分 |
| 20 | 华人健康 | -9.72% | 0.91% | 4.0分 |
| 22 | 健之佳 | -9.96% | 0.40% | 3.9分 |
| 24 | 达嘉维康 | -11.68% | 0.77% | 4.3分 |
| 26 | 药易购 | -12.79% | 1.20% | 3.7分 |
| 28 | 合富中国 | -13.57% | 1.43% | 4.1分 |
| 30 | 润达医疗 | -20.89% | -3.85% | 3.2分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 4/72 ， 1/72。
[{"date":"2024-09-30","value":"11.07","vol":"5.85"},{"date":"2024-06-30","value":"7.97","vol":"4.44"},{"date":"2024-03-31","value":"4.03","vol":"2.30"},{"date":"2023-12-31","value":"15.38","vol":"7.23"},{"date":"2023-09-30","value":"11.14","vol":"7.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
11.07 | 7.97 | 4.03 | 15.38 | 11.14 |
| 行业(%) | 5.85 | 4.44 | 2.30 | 7.23 | 7.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"40.39","vol":"17.89"},{"date":"2024-06-30","value":"40.05","vol":"17.84"},{"date":"2024-03-31","value":"39.25","vol":"17.80"},{"date":"2023-12-31","value":"38.21","vol":"17.83"},{"date":"2023-09-30","value":"39.55","vol":"18.09"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
40.39 | 40.05 | 39.25 | 38.21 | 39.55 |
| 行业(%) | 17.89 | 17.84 | 17.80 | 17.83 | 18.09 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/72 ， 7/72。
[{"date":"2024-09-30","value":"8.38","vol":"2.06"},{"date":"2024-06-30","value":"9.86","vol":"1.88"},{"date":"2024-03-31","value":"13.39","vol":"4.80"},{"date":"2023-12-31","value":"13.59","vol":"4.27"},{"date":"2023-09-30","value":"19.03","vol":"6.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
8.38 | 9.86 | 13.39 | 13.59 | 19.03 |
| 行业(%) | 2.06 | 1.88 | 4.80 | 4.27 | 6.21 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"11.14","vol":"-50.40"},{"date":"2024-06-30","value":"13.13","vol":"-17.67"},{"date":"2024-03-31","value":"20.89","vol":"3.54"},{"date":"2023-12-31","value":"11.90","vol":"2.19"},{"date":"2023-09-30","value":"21.32","vol":"10.40"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
11.14 | 13.13 | 20.89 | 11.90 | 21.32 |
| 行业(%) | -50.40 | -17.67 | 3.54 | 2.19 | 10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 25/72 ， 27/72。
[{"date":"2024-09-30","value":"0.67","vol":"0.89"},{"date":"2024-06-30","value":"0.47","vol":"0.60"},{"date":"2024-03-31","value":"0.24","vol":"0.31"},{"date":"2023-12-31","value":"1.00","vol":"1.24"},{"date":"2023-09-30","value":"0.74","vol":"0.91"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.67 | 0.47 | 0.24 | 1.00 | 0.74 |
| 行业(次) | 0.89 | 0.60 | 0.31 | 1.24 | 0.91 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.66","vol":"4.52"},{"date":"2024-06-30","value":"1.86","vol":"3.08"},{"date":"2024-03-31","value":"0.96","vol":"1.58"},{"date":"2023-12-31","value":"3.76","vol":"6.32"},{"date":"2023-09-30","value":"2.71","vol":"4.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.66 | 1.86 | 0.96 | 3.76 | 2.71 |
| 行业(次) | 4.52 | 3.08 | 1.58 | 6.32 | 4.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"27.86","vol":"4.01"},{"date":"2024-06-30","value":"20.23","vol":"6.46"},{"date":"2024-03-31","value":"10.89","vol":"-3.83"},{"date":"2023-12-31","value":"26.00","vol":"10.23"},{"date":"2023-09-30","value":"28.45","vol":"2.62"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 27.86 | 20.23 | 10.89 | 26.00 | 28.45 |
| 行业 | 4.01 | 6.46 | -3.83 | 10.23 | 2.62 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.21","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.40","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.21 | - | 0.40 | - |
| 行业 | 0.00 | 0.77 | 0.00 | 1.02 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/72 ， 14/72。
[{"date":"2024-09-30","value":"1.19","vol":"1.47"},{"date":"2024-06-30","value":"1.22","vol":"1.49"},{"date":"2024-03-31","value":"1.26","vol":"1.51"},{"date":"2023-12-31","value":"1.08","vol":"1.51"},{"date":"2023-09-30","value":"1.08","vol":"1.48"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.19 | 1.22 | 1.26 | 1.08 | 1.08 |
| 行业 | 1.47 | 1.49 | 1.51 | 1.51 | 1.48 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.83","vol":"1.04"},{"date":"2024-06-30","value":"0.85","vol":"1.06"},{"date":"2024-03-31","value":"0.89","vol":"1.09"},{"date":"2023-12-31","value":"0.69","vol":"1.07"},{"date":"2023-09-30","value":"0.68","vol":"1.06"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.83 | 0.85 | 0.89 | 0.69 | 0.68 |
| 行业 | 1.04 | 1.06 | 1.09 | 1.07 | 1.06 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 10/72 ， 22/72。
[{"date":"2024-09-30","value":"59.94","vol":"61.64"},{"date":"2024-06-30","value":"58.74","vol":"61.18"},{"date":"2024-03-31","value":"57.69","vol":"61.00"},{"date":"2023-12-31","value":"56.72","vol":"60.66"},{"date":"2023-09-30","value":"54.32","vol":"61.05"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
59.94 | 58.74 | 57.69 | 56.72 | 54.32 |
| 行业(%) | 61.64 | 61.18 | 61.00 | 60.66 | 61.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.59","vol":"2.19"},{"date":"2024-06-30","value":"1.52","vol":"2.15"},{"date":"2024-03-31","value":"1.45","vol":"2.15"},{"date":"2023-12-31","value":"1.40","vol":"2.12"},{"date":"2023-09-30","value":"1.27","vol":"2.07"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.59 | 1.52 | 1.45 | 1.40 | 1.27 |
| 行业(%) | 2.19 | 2.15 | 2.15 | 2.12 | 2.07 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"7.44","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"8.88","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"12.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"14.12","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"15.69","blueLineValue":"1.31","type":"YC"}]